Gepotidacin, a new antibiotic pill, works as well as standard treatments for gonorrhea. These results appeared in a large, recent study published in The Lancet. The new drug could offer a simple oral option for treating this common sexually transmitted infection.
New RSV Shot Guidelines For Vulnerable Adults In Their 50s
The CDC reduced the minimum age for RSV vaccination. Adults aged 50 to 59 with risk factors now qualify. The Advisory Committee on Immunization Practices, or ACIP, voted 14-0 in favor. One member voted to abstain.
The recommendation targets adults at high risk of severe RSV symptoms. Qualifying conditions include heart disease, diabetes, asthma, COPD, chronic bronchitis, kidney disease, weakened immunity, and neurological disorders. These health issues are common in people over 50.
The “Urgent Threat” of Candida Auris: What You Should Know
A deadly fungus called Candida auris is spreading in U.S. hospitals. New research shows a major jump in cases since 2019. Only five infections were reported in the United States that year. By 2023, the number of cases jumped sharply to 115.
The fungus kills one in three people who become infected. It targets the elderly and people already sick or hospitalized. Experts say the spread is a growing threat to public health.
New Research Tests Treatment For Deadly Anthrax Infection
Scientists at the University of Pittsburgh have tested a new anthrax treatment. The treatment uses growth factors to help repair damaged lung tissue. It reversed advanced damage in mice with late-stage anthrax infections. This discovery could help patients who miss the usual treatment window.
Anthrax is caused by a bacterium called Bacillus anthracis. It can enter the body through the lungs, skin, or digestion. Early symptoms often look like the flu, making diagnosis difficult. Without fast treatment, anthrax becomes deadly within just a few days.
The new study offers hope for treating advanced or missed infections. Researchers believe this method could save lives in real-world outbreaks.
Surging Walking Pneumonia Cases: How To Stay Protected
Walking pneumonia cases are rising this year, especially among young children. The increase is linked to bacteria called Mycoplasma pneumoniae. These bacteria often cause mild respiratory illnesses, including walking pneumonia. While mild, walking pneumonia can still cause persistent and uncomfortable symptoms.
